Loading bill breakdown…
Loading bill breakdown…
Sponsored by Sen. Chuck Grassley (R-IA) · 13 active : 7 Republicans, 6 Democrats
Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
Prescription Pricing for the People Act of 20
25
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs.
The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs.
The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations.
Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.
Members fall into . All 100 senators have enough data to score.
Bars show each input from 0 to 100: ideology gap, scorecard gap, . is the seat’s partisan lean, and shows how much of the input data a score has.
Loading similar votes
Ideology is each member’s score. The cluster low on the chart includes the bill’s 14 sponsor and cosponsors in the Senate: they have already committed, so they score as entrenched.
Not applicable in the Senate. There is not enough similar voting history (weight 0.0 of 5.0 needed), so this input is left out of the score rather than counted as missing.
No similar roll calls in the Senate